Gene · 114609
Papers2,254
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 2,254
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| TRAM promotes Toll-like-receptor-free myddosome signal transduction. | Nature | 2026 | 42778610 | PubTator, text mining | PubMed |
| Nuclear localization of Toll/interleukin-1 receptor domain-containing adaptor protein reveals a previously unrecognized role in hepatic stellate cell activation. | Front Immunol | 2026 | 42698655 | PubTator, text mining | PubMed |
| Toll/IL-1 receptor domain-containing adaptor protein plays a crucial role in macrophage-mediated hepatic stellate cell activation in alcoholic liver disease. | Front Cell Dev Biol | 2026 | 42614271 | PubTator, text mining | PubMed |
| Roles of TIR domain-containing adaptor protein in tumor: Inflammation and immune regulation via toll-like receptor signaling. | J Int Med Res | 2026 | 42606330 | PubTator, text mining | PubMed |
| Genetic susceptibility to aseptic loosening following total hip and knee arthroplasty: a systematic review of candidate-gene and genome-wide association studies. | Br Med Bull | 2026 | 42574754 | PubTator, text mining | PubMed |
| MyD88-Family Adaptors: Compartmentalised Signalling and Non-Immune Functions. | Immunology | 2026 | 42552630 | PubTator, text mining | PubMed |
| Integrative Bioinformatics Prioritizes the TLR4 Axis and Candidate Non-Starch Polysaccharides in Hyperuricemia-Associated Inflammation. | Biology (Basel) | 2026 | 42510697 | PubTator, text mining | PubMed |
| The Dual Role of TLR2 in Breast Cancer: Implications for Therapeutic Targeting. | Immunol Invest | 2026 | 42446204 | PubTator, text mining | PubMed |
| A pyroptosis-related molecular signature stratifies prognosis and highlights GSDMB-mediated malignancy in intrahepatic cholangiocarcinoma. | Biol Direct | 2026 | 42098854 | PubTator, text mining | PubMed |
| Adaptor protein supersaturation drives innate immune signaling and cell fate. | Elife | 2026 | 41873950 | PubTator, text mining | PubMed |
| Enhancing cancer classification accuracy with a self-attention network using panel capture sequencing data. | Brief Bioinform | 2026 | 41870130 | PubTator, text mining | PubMed |
| DAB2IP: unifying cardiovascular pathogenesis and cardiovascular brain crosstalk. | Front Cardiovasc Med | 2026 | 41798622 | PubTator, text mining | PubMed |
| Toll-like receptor signaling outcome is determined by the stoichiometry of the endogenous TRIFosome. | Sci Adv | 2026 | 41790885 | PubTator, text mining | PubMed |
| Cytoprotective role of octacosanol in lipopolysaccharide-induced inflammation. | Front Immunol | 2026 | 41756299 | PubTator, text mining | PubMed |
| The interplay of dietary sugar, chronic inflammation, and bladder cancer: mechanistic insights, evidence, and prevention strategies. | Front Immunol | 2026 | 41737225 | PubTator, text mining | PubMed |
| Macrophage makeover extreme viral edition: mechanisms of immune subversion and therapeutic perspectives. | J Gen Virol | 2026 | 41729693 | PubTator, text mining | PubMed |
| IFN-γ-induced trained immunity enhances killing of priority pathogens in healthy and genetically vulnerable individuals. | JCI Insight | 2026 | 41665962 | PubTator, text mining | PubMed |
| Absence of conserved immune signalling pathways and increased pathogen susceptibility associated to photosymbiosis in acoels. | BMC Biol | 2026 | 41578329 | PubTator, text mining | PubMed |
| Immunomodulatory effects of the TIRAP/MAL rs8177374 (S180L) variant: Meta-Analytic evidence from severe and Plasmodium falciparum malaria. | Microb Pathog | 2026 | 41352519 | PubTator, text mining | PubMed |
| Evaluation of Immune Risk Factors for Developing Complications After Bacterial Meningitis in Children. | J Child Neurol | 2026 | 40956914 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/114609/papers